fda compounding semaglutide warning 2025 october National Hispanic Medical Association | After compounded GLP-1 drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and FDA Decisions Expected: October 2025

Weight loss on its own can change muscle, bone and more

Is Hers the right weight loss platform for you

Weighing risk versus benefit is key here, but both Levy and Salas-Whalen pointed out that untreated obesity carries risks and shouldn't be overlooked

This makes it a triple agonist , interacting with the following receptors to promote fat burning, blood sugar control, and appetite reduction: GLP-1 (Glucagon-like peptide-1) GIP (Glucose-dependent insulinotropic polypeptide) GCG (Glucagon) Weekly Injection with Long-Lasting Effects Administered as a weekly injection, Retatrutide stays active in the body for approximately six days

In select locations, dedicated product displays highlight items that can help manage common issues such as nausea and gastrointestinal discomfort, as well as products that support hydration, protein intake, and overall nutrition